AUG 11, 2016 7:29 AM PDT

A New Case for Why Heart Cancer is Rare

WRITTEN BY: Xuan Pham
In 2014 the most common cancer diagnosis was breast cancer, followed by prostate, lung, colon, skin, and brain cancer. By contrast, the Mayo clinic estimated that leading hospitals around the country see less than one case of heart cancer every year. The reason for this could be due to natural selection putting severe pressure on this organ, as purported by researchers in the latest Opinion piece published in Trends in Cancer.

Natural selection protects the heart from cancer? | Image: pixabay.com
 
"The organs that are the most important to keeping you alive and capable of reproduction, such as the heart, brain, or uterus, may enjoy a better protection against cancer, all other things being equal," said Frédéric Thomas, who is an evolutionary biologist at the Center for Ecological and Evolutionary Cancer Research in France.
 
This evolution-based idea is in line with what we already know about the cell biology of the heart and cancer. For example, we know risks for cancer increases with more cycles of cell division, which is relatively low for heart cells. Unlike skin or colon cells that are constantly dividing and shedding, heart cells don’t usually participate in this renewal process (unless there’s been damages). With such few cell divisions, heart cells have very small chances of accumulating enough mutations to become cancerous.

Heart cancer is also thought to be rare because the heart doesn’t get exposed to too many external carcinogens, other than those found in blood. This also significantly lowers the mutation rate of heart cells. Thomas argues that evolutionary selection is behind the protection that seemingly surrounds the heart and other vital organs that don’t come in pairs.
 
"Organs that are large or in pairs could potentially accumulate larger numbers of oncogenic manifestations without being impaired, whereas small and important organs like the pancreas could be easily compromised with only a few tumors inside," said Thomas. Very simply speaking, these single organs have a very high protection against mutations because there just isn’t another backup copy.
 
This hypothesis seems to be consistent with the heart and cancer. However, it doesn’t seem to explain why cancer incidences are much higher in other single vital organs like the pancreas and brain. In response, Thomas said, “"We are not saying that this is the main factor to explain the different susceptibility of organs to cancer, but it is a factor that contributes with others."
 
Though rare, heart cancer is possible, and it usually involves cancer from other nearby organs like the breast, kidney, and lung. Elsewhere in the body, cancer can also migrate large distances to affect the heart. And while the chances of getting heart cancer is low, we still need to remember to take good care of this vital organ because heart disease is still among one of the biggest killers for adults.
 

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JAN 26, 2021
Clinical & Molecular DX
Prostate Cancer Screening: No More False Positives
JAN 26, 2021
Prostate Cancer Screening: No More False Positives
A new diagnostic test powered by artificial intelligence has been found to detect prostate cancer markers in urine sampl ...
JAN 28, 2021
Cancer
Research shows 4 in 10 cancer deaths are from cigarette smoking
JAN 28, 2021
Research shows 4 in 10 cancer deaths are from cigarette smoking
No really, put down that cigarette. New research attributes 4 in 10 cancer deaths in the Southern US and Appalachia to c ...
FEB 08, 2021
Microbiology
Fecal Transplants May Improve Cancer Treatment Efficacy
FEB 08, 2021
Fecal Transplants May Improve Cancer Treatment Efficacy
Humans carry around trillions of microbes, and the ones in our guts - the gut microbiome - plays an essential role in ou ...
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
FEB 12, 2021
Cancer
A behavioral science approach to FIT kits
FEB 12, 2021
A behavioral science approach to FIT kits
Researchers from the Perelman School of Medicine at the University of Pennsylvania have a new strategy to promoting colo ...
FEB 24, 2021
Cancer
Inducing ferroptosis in neuroblastoma cells
FEB 24, 2021
Inducing ferroptosis in neuroblastoma cells
New research published in the journal Cancer Research describes the process by which iron can trigger cell death in ...
Loading Comments...